Infectious Diseases
1606 articles · 54 journals
Journals in this subcategory (54)
- Clinical Microbiology and Infection · Elsevier (90)
- Journal of Migration and Health · Elsevier (89)
- IDCases · Elsevier (87)
- Clinical Infection in Practice · Elsevier (80)
- Journal of Hospital Infection · Elsevier (79)
- Infection Prevention in Practice · Elsevier (78)
- The Lancet Infectious Diseases · Elsevier (78)
- New Microbes and New Infections · Elsevier (75)
- Acta Tropica · Elsevier (71)
- Journal of Infection and Chemotherapy · Elsevier (69)
- Tropical Medicine and International Health · Wiley (68)
- Journal of Microbiology, Immunology and Infection · Elsevier (65)
- Indian Journal of Tuberculosis · Elsevier (62)
- Diagnostic Microbiology and Infectious Disease · Elsevier (56)
- Hepatology Research · Wiley (44)
- Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · Elsevier (44)
- Anaerobe · Elsevier (39)
- Infection, Disease & Health · Elsevier (37)
- The Lancet HIV · Elsevier (37)
- Microbial Risk Analysis · Elsevier (36)
- Ticks and Tick-borne Diseases · Elsevier (35)
- Journal of Clinical Virology · Elsevier (34)
- Transplant Infectious Disease · Wiley (33)
- Biosafety and Health · Elsevier (30)
- Travel Medicine and Infectious Disease · Elsevier (28)
- Infectious Diseases Now · Elsevier (22)
- Journal of Medical Virology · Wiley (22)
- Reviews in Medical Virology · Wiley (19)
- Spatial and Spatio-temporal Epidemiology · Elsevier (19)
- Vacunas · Elsevier (18)
- Zoonoses and Public Health · Wiley (18)
- Influenza and other Respiratory Viruses · Wiley (13)
- Clinical Microbiology Newsletter · Elsevier (8)
- The Brazilian Journal of Infectious Diseases · Elsevier (8)
- Mycoses · Wiley (7)
- Journal of the International AIDS Society · Wiley (5)
- Helicobacter · Wiley (3)
- AIDS and Behavior · Springer Nature (0)
- Annals of Clinical Microbiology and Antimicrobials · Springer Nature (0)
- BMC Infectious Diseases · Springer Nature (0)
- Current Fungal Infection Reports · Springer Nature (0)
- Current HIV/AIDS Reports · Springer Nature (0)
- Current Infectious Disease Reports · Springer Nature (0)
- Current Tropical Medicine Reports · Springer Nature (0)
- Gut Pathogens · Springer Nature (0)
- Hepatology Research · Springer Nature (0)
- Infection · Springer Nature (0)
- Journal of Ophthalmic Inflammation and Infection · Springer Nature (0)
- Malaria Journal · Springer Nature (0)
- Parasitology Research · Springer Nature (0)
- Retrovirology · Springer Nature (0)
- Tropical Diseases, Travel Medicine and Vaccines · Springer Nature (0)
- Tropical Medicine and Health · Springer Nature (0)
- Virology Journal · Springer Nature (0)
- Epidemiology and management of HIV-2
- Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care
- Andes virus management—balancing infection control with patient safety and autonomy
- Reimagining HIV service integration
- Funobactam for hospital-acquired pneumonia and ventilator-associated pneumonia: promising evidence, unanswered questions
- Aftershocks: Trump 2.0, Public Health, and Our Better Angels, José M Zuniga. Gatekeeper Press (2026), 534, ISBN: 9781662976346
- Imipenem–cilastatin–funobactam versus imipenem–cilastatin–relebactam in patients with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia: a phase 3, double-blind, non-inferiority randomised trial
- Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study
- South Africa's paediatric HIV tracking gap
- Fiji's national HIV emergency
- Combination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma
- Humoral immunity after mRNA SARS-CoV-2 XFG vaccination
- Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial
- Maternal and perinatal outcomes in pregnant women with Lassa fever: analysis from the LASCOPE prospective cohort study
- Expanding access to lenacapavir in low-income and middle-income countries
- Low-level viraemia in children living with HIV
- Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study
- Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study
- Epidemiological trends of HIV among individuals aged 15–54 years in South Africa from 2004 to 2025: a population-based, longitudinal cohort study
- Targeted point-of-care HIV testing at birth for newborns at high risk of vertical transmission in Botswana: a prospective cohort study
- Virological failure and treatment interruption among people with unsuppressed viral load on antiretroviral therapy: a cross-sectional analysis of Population-based HIV Impact Assessment surveys in seven sub-Saharan African countries
- The present and future of HIV and viral hepatitis co-infection
- Antiretroviral therapy, adiposity, and cardiometabolic risk in people with HIV
- Weight management in people with HIV
- When race predicts weight gain on ART, what does it mean?
- HIV, obesity, and stigma: lessons for programmes, policy, and practice
- Safety, pharmacokinetics, and antiviral activity of a combination of TMB-365 and TMB-380 in people living with HIV suppressed with antiretroviral therapy in the USA: a phase 1b/2a, open-label, dose-escalation study
- The “Porto Alegre HIV Charter”: Confronting the HIV epidemic in Rio Grande do Sul, Southern Brazil
- Older people living with HIV: a population with high prevalence and severity of metabolic dysfunction-associated steatotic liver disease ‒ A cross-sectional study
- Gestational and congenital syphilis in a Brazilian harbor city: A population-based study of prevalence, determinants, and adverse neonatal outcomes